Enfusion, Inc. (NYSE:ENFN) Q3 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. Thank you for standing by. Welcome to Enfusion’s Third Quarter 2024 Earnings Conference Call.
Enfusion Inc. (ENFN)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | PDT Partners Peter Muller | 0 | $0 | 0% | |
| 2. | Glazer Capital Paul Glazer | 0 | $0 | 0% | |
| 3. | Millennium Management Israel Englander | 0 | $0 | 0% | |
| 4. | Nellore Capital Management Sakya Duvvuru | 0 | $0 | 0% | |
| 5. | Schonfeld Strategic Advisors Ryan Tolkin (Cio) | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.00 | 722,707 | $12,286,019.00 | 722,707 | 2021-10-25 | Filing | |
| $17.00 | 538,887 | $9,161,079.00 | 538,887 | 2021-10-25 | Filing | |
| $17.00 | 722,707 | $12,286,019.00 | 722,707 | 2021-10-25 | Filing | |
| $17.00 | 538,887 | $9,161,079.00 | 538,887 | 2021-10-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.38 | 3,126 | $35,558.25 | 221,875 | 2025-03-05 | Filing | |
| $11.38 | 1,695 | $19,280.63 | 70,946 | 2025-03-05 | Filing | |
| $11.39 | 11,452 | $130,472.64 | 631,847 | 2025-03-06 | Filing | |
| $11.38 | 14,560 | $165,620.00 | 1,217,067 | 2025-03-05 | Filing | |
| $11.38 | 542 | $6,165.25 | 47,622 | 2025-03-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 104,821 | $1,163,513 | 0% | |
| 2. | 1,965 | $20,238 | 0% | |
| 3. | 1 | $11 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
20 Fintech Stocks Riding the AI Wave Higher
Artificial intelligence (AI) is redefining how financial services operate, bringing new waves of innovation while enhancing efficiency and decision-making across the sector.
Should You Believe in Enfusion’s (ENFN) Healthy Revenue Growth And Margin Expansion in the Future?
Next Century Growth Investors, LLC, an investment Management Company, released its “Small Cap Strategy” second-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Enfusion, Inc. (NYSE:ENFN) Q2 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen. Thank you for standing by. Welcome to Enfusion Second Quarter 2024 Earnings Conference Call.
Enfusion, Inc. (NYSE:ENFN) Q1 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. Thank you for standing by. Welcome to Enfusion’s First Quarter 2024 Earnings Conference Call.
Will Enfusion (ENFN) Grow Revenue And Expand Margins In The Future?
Next Century Growth Investors, LLC, an investment Management Company, released its “Micro-Cap Strategy” fourth-quarter investor letter. A copy of the letter can be downloaded here.
Enfusion, Inc. (NYSE:ENFN) Q4 2023 Earnings Call Transcript
Enfusion, Inc. misses on earnings expectations. Reported EPS is $0.04 EPS, expectations were $0.06. Enfusion, Inc.
Enfusion, Inc. (NYSE:ENFN) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to Enfusion's Third Quarter 2023 Earnings Conference Call.
Enfusion, Inc. (NYSE:ENFN) Q2 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and thank you for standing by. Welcome to Enfusion Second Quarter 2023 Earnings Conference Call.
Hedge Fund and Insider Trading News: Ken Griffin, Crispin Odey, Ray Dalio, Irenic Capital Management, Elliott Management, BFAM Partners, Comtech Telecomm. Corp. (CMTL), Zymeworks Inc. (ZYME), and More
A group of partners at Odey Asset Management has announced the removal of Crispin Odey, the prominent City tycoon and donor to the Conservative Party, from the hedge fund he established, in response to...
Billionaire Hedge Funds
